GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (OTCPK:CNVVY) » Definitions » Earnings per Share (Diluted)

CNVVY (ConvaTec Group) Earnings per Share (Diluted) : $0.30 (TTM As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is ConvaTec Group Earnings per Share (Diluted)?

ConvaTec Group's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was $0.15. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.30.

ConvaTec Group's EPS (Basic) for the six months ended in Jun. 2024 was $0.15. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.30.

ConvaTec Group's EPS without NRI for the six months ended in Jun. 2024 was $0.27. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was $0.54.

During the past 12 months, ConvaTec Group's average EPS without NRIGrowth Rate was 1.00% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 6.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -0.90% per year.

During the past 11 years, ConvaTec Group's highest 3-Year average EPS without NRI Growth Rate was 175.00% per year. The lowest was -9.20% per year. And the median was 5.00% per year.


ConvaTec Group Earnings per Share (Diluted) Historical Data

The historical data trend for ConvaTec Group's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ConvaTec Group Earnings per Share (Diluted) Chart

ConvaTec Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.22 0.23 0.12 0.25

ConvaTec Group Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.03 0.11 0.14 0.15

Competitive Comparison of ConvaTec Group's Earnings per Share (Diluted)

For the Medical Instruments & Supplies subindustry, ConvaTec Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ConvaTec Group's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ConvaTec Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where ConvaTec Group's PE Ratio falls into.



ConvaTec Group Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

ConvaTec Group's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(130.3-0)/513.147
=0.25

ConvaTec Group's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2024 is calculated as

Diluted Earnings Per Share (Q: Jun. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(78.6-0)/513.988
=0.15

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


ConvaTec Group  (OTCPK:CNVVY) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


ConvaTec Group Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of ConvaTec Group's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


ConvaTec Group Business Description

Traded in Other Exchanges
Address
20 Eastbourne Terrace, 7th Floor, Paddington, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue.

ConvaTec Group Headlines